Published in Neurology on July 24, 2015
Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology (2016) 1.07
Seizures and gliomas - towards a single therapeutic approach. Nat Rev Neurol (2016) 0.83
Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys (2016) 0.80
Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol (2016) 0.79
Author Response. Neurology (2016) 0.75
The effects of sequential treatments on hippocampal volumes in malignant glioma patients. J Neurooncol (2016) 0.75
The effect of IDH1 mutation on the structural connectome in malignant astrocytoma. J Neurooncol (2016) 0.75
Highlights from the Literature. Neuro Oncol (2016) 0.75
Comment: Chemoradiotherapy for glioblastoma patients--the double-edged sword. Neurology (2015) 0.75
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage (2006) 18.68
A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage (2010) 6.24
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol (2012) 6.20
Irradiation induces neural precursor-cell dysfunction. Nat Med (2002) 5.46
Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol (2011) 3.69
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst (1998) 3.67
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer (2004) 3.50
Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol (2002) 3.13
Cognitive deficits in adult patients with brain tumours. Lancet Neurol (2004) 2.71
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer (1999) 2.68
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer (2007) 2.43
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol (2006) 2.34
Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry (2005) 2.18
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A (2013) 2.14
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol (2008) 1.71
Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol (2012) 1.65
Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res (2006) 1.62
Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist (2008) 1.57
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp (2011) 1.40
Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study. Int J Radiat Oncol Biol Phys (2008) 1.39
Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol (2005) 1.35
Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp (2011) 1.31
Cranial irradiation compromises neuronal architecture in the hippocampus. Proc Natl Acad Sci U S A (2013) 1.28
Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun (2012) 1.27
Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol (2011) 1.25
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat (2011) 1.16
Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer (2008) 1.14
Regional variation in brain white matter diffusion index changes following chemoradiotherapy: a prospective study using tract-based spatial statistics. PLoS One (2013) 1.03
Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev (2013) 1.02
Radiation therapy effects on white matter fiber tracts of the limbic circuit. Med Phys (2012) 0.99
MRI upsampling using feature-based nonlocal means approach. IEEE Trans Med Imaging (2014) 0.98
Dataset of magnetic resonance images of nonepileptic subjects and temporal lobe epilepsy patients for validation of hippocampal segmentation techniques. Neuroinformatics (2011) 0.96
Neural correlates of chemotherapy-related cognitive impairment. Cortex (2014) 0.88
Mapping ventricular expansion onto cortical gray matter in older adults. Neurobiol Aging (2014) 0.87
Longitudinal CT study of parenchymal brain changes in glioma survivors. AJNR Am J Neuroradiol (1988) 0.83